Works by Mancuso, James P.

Results: 28

Efficacy of ertugliflozin in monotherapy or combination therapy in patients with type 2 diabetes: A pooled analysis of placebo-controlled studies.
Published in:
Diabetes & Vascular Disease Research, 2019, v. 16, n. 5, p. 415, doi. 10.1177/1479164119842513
By:
- Liu, Jie;
- Tarasenko, Lisa;
- Terra, Steven G;
- Huyck, Susan;
- Wu, Larry;
- Pong, Annpey;
- Calle, Roberto A;
- Gallo, Silvina;
- Darekar, Amanda;
- Mancuso, James P
Publication type:
Article
Long‐term weight loss and cardiorenal outcomes by baseline BMI in the VERTIS CV trial.
Published in:
Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 583, doi. 10.1111/dom.16050
By:
- Cosentino, Francesco;
- Dagogo‐Jack, Samuel;
- Frederich, Robert;
- Cannon, Christopher P.;
- Cherney, David Z. I.;
- Mancuso, James P.;
- Wynant, Willy;
- Xing, Aiwen;
- Gantz, Ira;
- Cater, Nilo B.;
- Pratley, Richard E.
Publication type:
Article
Effects of ertugliflozin on uric acid and gout‐related outcomes in persons with type 2 diabetes and cardiovascular disease: Post hoc analyses from VERTIS CV.
Published in:
Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5336, doi. 10.1111/dom.15895
By:
- Sridhar, Vikas S.;
- Cosentino, Francesco;
- Dagogo‐Jack, Samuel;
- McGuire, Darren K.;
- Pratley, Richard E.;
- Cater, Nilo B.;
- Noyes Essex, Margaret;
- Mancuso, James P.;
- Zhao, Yujie;
- Cherney, David Z. I.
Publication type:
Article
Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease.
Published in:
Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1398, doi. 10.1111/dom.14965
By:
- Kim, Joseph M.;
- Bhatt, Deepak L.;
- Dagogo‐Jack, Samuel;
- Cherney, David Z. I.;
- Cosentino, Francesco;
- McGuire, Darren K.;
- Pratley, Richard E.;
- Liu, Chih‐Chin;
- Cater, Nilo B.;
- Frederich, Robert;
- Mancuso, James P.;
- Cannon, Christopher P.
Publication type:
Article
Cardiorenal outcomes with ertugliflozin assessed according to baseline glucose‐lowering agent: An analysis from VERTIS CV.
Published in:
Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1245, doi. 10.1111/dom.14691
By:
- Dagogo‐Jack, Samuel;
- Cannon, Christopher P.;
- Cherney, David Z. I.;
- Cosentino, Francesco;
- Liu, Jie;
- Pong, Annpey;
- Gantz, Ira;
- Frederich, Robert;
- Mancuso, James P.;
- Pratley, Richard E.
Publication type:
Article
Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The VERTIS FACTORIAL randomized trial.
Published in:
Diabetes, Obesity & Metabolism, 2018, v. 20, n. 5, p. 1111, doi. 10.1111/dom.13194
By:
- Pratley, Richard E.;
- Eldor, Roy;
- Raji, Annaswamy;
- Golm, Gregory;
- Huyck, Susan B.;
- Sunga, Sheila;
- Johnson, Jeremy;
- Engel, Samuel S.;
- Lauring, Brett;
- Qiu, Yanping;
- Terra, Steven G.;
- Mancuso, James P.
Publication type:
Article
Efficacy and safety of the addition of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sitagliptin: The VERTIS SITA2 placebo‐controlled randomized study.
Published in:
Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 530, doi. 10.1111/dom.13116
By:
- Dagogo‐jack, Samuel;
- Liu, Jie;
- Eldor, Roy;
- Amorin, Guillermo;
- Johnson, Jeremy;
- Hille, Darcy;
- Liao, Yuqin;
- Huyck, Susan;
- Golm, Gregory;
- Terra, Steven G.;
- Mancuso, James P.;
- Engel, Samuel S.;
- Lauring, Brett
Publication type:
Article
Efficacy and safety of ertugliflozin across racial groups in patients with type 2 diabetes mellitus.
Published in:
2020
By:
- Liu, Jie;
- Tarasenko, Lisa;
- Pong, Annpey;
- Huyck, Susan;
- Wu, Larry;
- Patel, Shrita;
- Hickman, Anne;
- Mancuso, James P.;
- Gantz, Ira;
- Terra, Steven G.
Publication type:
journal article
Efficacy and safety of ertugliflozin in Hispanic/Latino patients with type 2 diabetes mellitus.
Published in:
2020
By:
- Liu, Jie;
- Tarasenko, Lisa;
- Pong, Annpey;
- Huyck, Susan;
- Patel, Shrita;
- Hickman, Anne;
- Mancuso, James P.;
- Ellison, Misoo C.;
- Gantz, Ira;
- Terra, Steven G.
Publication type:
journal article
Results of VERTIS SU extension study: safety and efficacy of ertugliflozin treatment over 104 weeks compared to glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin.
Published in:
2019
By:
- Hollander, Priscilla;
- Hill, Julie;
- Johnson, Jeremy;
- Wei Jiang, Zhi;
- Golm, Gregory;
- Huyck, Susan;
- Terra, Steven G.;
- Mancuso, James P.;
- Engel, Samuel S.;
- Lauring, Brett;
- Liu, Jie
Publication type:
journal article
Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial.
Published in:
European Heart Journal, 2023, v. 44, n. 48, p. 5163, doi. 10.1093/eurheartj/ehad639
By:
- Pandey, Ambarish;
- Kolkailah, Ahmed A;
- Cosentino, Francesco;
- Cannon, Christopher P;
- Frederich, Robert C;
- Cherney, David Z I;
- Dagogo-Jack, Samuel;
- Pratley, Richard E;
- Cater, Nilo B;
- Gantz, Ira;
- Mancuso, James P;
- McGuire, Darren K
Publication type:
Article
Comprehensive implementations of multiple imputation using retrieved dropouts for continuous endpoints.
Published in:
BMC Medical Research Methodology, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12874-025-02494-5
By:
- Wang, Shuai;
- Schwartz, Pamela F.;
- Mancuso, James P.
Publication type:
Article
Do Methodological Flaws Invalidate a Randomized Trial of Lifestyle Modification Programs in Obese Patients?
Published in:
2009
By:
- Berger, Vance W.;
- Mancuso, James P.;
- Gerber, Robert A.;
- Digenio, Andres G.
Publication type:
Letter
Comparison of methods for delivering a lifestyle modification program for obese patients: a randomized trial.
Published in:
2009
By:
- Digenio AG;
- Mancuso JP;
- Gerber RA;
- Dvorak RV;
- Digenio, Andres G;
- Mancuso, James P;
- Gerber, Robert A;
- Dvorak, Roman V
Publication type:
journal article
Comparison of Methods for Delivering a Lifestyle Modification Program for Obese Patients.
Published in:
Annals of Internal Medicine, 2009, v. 150, n. 4, p. 255, doi. 10.7326/0003-4819-150-4-200902170-00006
By:
- Digenio, Andres G.;
- Mancuso, James P.;
- Gerber, Robert A.;
- Dvorak, Roman V.
Publication type:
Article
Increased Food Intake and Energy Expenditure Following Administration of Olanzapine to Healthy Men.
Published in:
Obesity (19307381), 2010, v. 18, n. 8, p. 1646, doi. 10.1038/oby.2010.6
By:
- Fountaine, Robert J.;
- Taylor, Ann E.;
- Mancuso, James P.;
- Greenway, Frank L.;
- Byerley, Lauri O.;
- Smith, Steven R.;
- Most, Marlene M.;
- Fryburg, David A.
Publication type:
Article
Ertugliflozin and incident obstructive sleep apnea: an analysis from the VERTIS CV trial.
Published in:
Sleep & Breathing, 2023, v. 27, n. 2, p. 669, doi. 10.1007/s11325-022-02594-2
By:
- Wojeck, Brian S.;
- Inzucchi, Silvio E.;
- Neeland, Ian J.;
- Mancuso, James P.;
- Frederich, Robert;
- Masiukiewicz, Urszula;
- Cater, Nilo B.;
- McGuire, Darren K.;
- Cannon, Christopher P.;
- Yaggi, Henry Klar
Publication type:
Article
Effects of ertugliflozin on renal function over 104 weeks of treatment: a post hoc analysis of two randomised controlled trials.
Published in:
Diabetologia, 2020, v. 63, n. 6, p. 1128, doi. 10.1007/s00125-020-05133-4
By:
- Cherney, David Z. I.;
- Heerspink, Hiddo J. L.;
- Frederich, Robert;
- Maldonado, Mario;
- Liu, Jie;
- Pong, Annpey;
- Xu, Zhi J.;
- Patel, Shrita;
- Hickman, Anne;
- Mancuso, James P.;
- Gantz, Ira;
- Terra, Steven G.
Publication type:
Article
Safety of Ertugliflozin in Patients with Type 2 Diabetes Mellitus: Pooled Analysis of Seven Phase 3 Randomized Controlled Trials.
Published in:
Diabetes Therapy, 2020, v. 11, n. 6, p. 1347, doi. 10.1007/s13300-020-00803-3
By:
- Patel, Shrita;
- Hickman, Anne;
- Frederich, Robert;
- Johnson, Susan;
- Huyck, Susan;
- Mancuso, James P.;
- Gantz, Ira;
- Terra, Steven G.
Publication type:
Article
Ertugliflozin and Sitagliptin Co-initiation in Patients with Type 2 Diabetes: The VERTIS SITA Randomized Study.
Published in:
Diabetes Therapy, 2018, v. 9, n. 1, p. 253, doi. 10.1007/s13300-017-0358-0
By:
- Miller, Sam;
- Krumins, Tania;
- Zhou, Haojin;
- Huyck, Susan;
- Johnson, Jeremy;
- Golm, Gregory;
- Terra, Steven G.;
- Mancuso, James P.;
- Engel, Samuel S.;
- Lauring, Brett
Publication type:
Article
Ertugliflozin Compared with Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: The VERTIS SU Randomized Study.
Published in:
Diabetes Therapy, 2018, v. 9, n. 1, p. 193, doi. 10.1007/s13300-017-0354-4
By:
- Hollander, Priscilla;
- Liu, Jie;
- Hill, Julie;
- Johnson, Jeremy;
- Jiang, Zhi Wei;
- Golm, Gregory;
- Huyck, Susan;
- Terra, Steven G.;
- Mancuso, James P.;
- Engel, Samuel S.;
- Lauring, Brett
Publication type:
Article
Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized Study.
Published in:
Diabetes Therapy, 2018, v. 9, n. 1, p. 49, doi. 10.1007/s13300-017-0337-5
By:
- Grunberger, George;
- Camp, Sarah;
- Johnson, Jeremy;
- Huyck, Susan;
- Terra, Steven G.;
- Mancuso, James P.;
- Jiang, Zhi Wei;
- Golm, Gregory;
- Engel, Samuel S.;
- Lauring, Brett
Publication type:
Article
Age-Adjusted Exact Trend Tests in the Event of Rare Occurrences.
Published in:
Biometrics, 2002, v. 58, n. 2, p. 403, doi. 10.1111/j.0006-341X.2002.00403.x
By:
- Mancuso, Jessica Y.;
- Ahn, Hongshik;
- Chen, James J.;
- Mancuso, James P.
Publication type:
Article
796-P: Cardiorenal Outcomes with Ertugliflozin by Baseline Cardiorenal Medications: An Analysis from VERTIS CV.
Published in:
Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-796-P
By:
- CHERNEY, DAVID;
- COSENTINO, FRANCESCO;
- MCGUIRE, DARREN K.;
- CHARBONNEL, BERNARD;
- DAGOGO-JACK, SAMUEL;
- PRATLEY, RICHARD E.;
- SHIH, WEICHUNG J.;
- MALDONADO, MARIO;
- PONG, ANNPEY;
- GANTZ, IRA;
- FREDERICH, ROBERT;
- MANCUSO, JAMES P.;
- MASIUKIEWICZ, URSZULA;
- CANNON, CHRISTOPHER P.
Publication type:
Article
786-P: Glycemic Efficacy and Safety of Ertugliflozin (ERTU) in Patients with Type 2 Diabetes (T2D) and Chronic Kidney Disease Stage 3 (CKD 3): An Analysis from VERTIS CV.
Published in:
Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-786-P
By:
- DAGOGO-JACK, SAMUEL;
- PRATLEY, RICHARD E.;
- CHERNEY, DAVID;
- CHARBONNEL, BERNARD;
- MCGUIRE, DARREN K.;
- COSENTINO, FRANCESCO;
- SHIH, WEICHUNG J.;
- LIU, JIE;
- FREDERICH, ROBERT;
- MANCUSO, JAMES P.;
- RAJI, ANNASWAMY;
- GANTZ, IRA
Publication type:
Article
783-P: Cardiorenal Outcomes with Ertugliflozin by Baseline (BL) Glucose-Lowering Agent (GLA): An Analysis from VERTIS CV.
Published in:
Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-783-P
By:
- CHARBONNEL, BERNARD;
- DAGOGO-JACK, SAMUEL;
- CANNON, CHRISTOPHER P.;
- CHERNEY, DAVID;
- COSENTINO, FRANCESCO;
- MCGUIRE, DARREN K.;
- SHIH, WEICHUNG J.;
- LIU, JIE;
- PONG, ANNPEY;
- GANTZ, IRA;
- FREDERICH, ROBERT;
- MANCUSO, JAMES P.;
- PRATLEY, RICHARD E.
Publication type:
Article
1197-P: Two-Year Effects of Ertugliflozin on Renal Function.
Published in:
Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1197-P
By:
- CHERNEY, DAVID;
- HEERSPINK, HIDDO L.;
- FREDERICH, ROBERT;
- MALDONADO, MARIO;
- PONG, ANNPEY;
- XU, ZHI JIN;
- LIU, JIE;
- MANCUSO, JAMES P.;
- GANTZ, IRA;
- TERRA, STEVEN G.
Publication type:
Article
2353-PUB: Efficacy and Safety of Ertugliflozin in Hispanic/Latino Patients (Pts) with Type 2 Diabetes Mellitus (T2DM).
Published in:
Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-2353-PUB
By:
- LIU, JIE;
- TARASENKO, LISA;
- ELLISON, MISOO C.;
- PONG, ANNPEY;
- HUYCK, SUSAN;
- MANCUSO, JAMES P.;
- TERRA, STEVEN G.;
- GANTZ, IRA
Publication type:
Article